Product NDC: | 13537-354 |
Proprietary Name: | Esika |
Non Proprietary Name: | OCTINOXATE and TITANIUM DIOXIDE |
Active Ingredient(s): | .02; .044 g/g; g/g & nbsp; OCTINOXATE and TITANIUM DIOXIDE |
Administration Route(s): | TOPICAL |
Dosage Form(s): | POWDER |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 13537-354 |
Labeler Name: | Ventura Corporation (San Juan, P.R) |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part352 |
Marketing Category: | OTC MONOGRAPH NOT FINAL |
Start Marketing Date: | 20110724 |
Package NDC: | 13537-354-02 |
Package Description: | 1 JAR in 1 BOX (13537-354-02) > 15 g in 1 JAR (13537-354-01) |
NDC Code | 13537-354-02 |
Proprietary Name | Esika |
Package Description | 1 JAR in 1 BOX (13537-354-02) > 15 g in 1 JAR (13537-354-01) |
Product NDC | 13537-354 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | OCTINOXATE and TITANIUM DIOXIDE |
Dosage Form Name | POWDER |
Route Name | TOPICAL |
Start Marketing Date | 20110724 |
Marketing Category Name | OTC MONOGRAPH NOT FINAL |
Labeler Name | Ventura Corporation (San Juan, P.R) |
Substance Name | OCTINOXATE; TITANIUM DIOXIDE |
Strength Number | .02; .044 |
Strength Unit | g/g; g/g |
Pharmaceutical Classes |